12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
1 other identifier
interventional
1,394
2 countries
189
Brief Summary
The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Nov 2013
189 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 5, 2013
CompletedFirst Posted
Study publicly available on registry
November 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedResults Posted
Study results publicly available
March 21, 2019
CompletedDecember 26, 2019
December 1, 2019
1.4 years
November 5, 2013
December 13, 2018
December 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Durable Overall CSBM Responders , Mean Replacement Approach
A durable overall CSBM responder was defined as a weekly CSBM responder for at least 9 of the 12 treatment weeks, included at least 3 of the last 4 weeks. A CSBM weekly responder was defined as a patient who has ≥ 3 Complete Spontaneous Bowel Movements (CSBMs) per week and an increase from baseline of ≥1 CSBM for that week. A CSBM was a bowel movement that occurred in the absence of laxative use within 24 hours and was associated with the feeling of complete evacuation.
12-week Treatment Period
Secondary Outcomes (4)
Change From Baseline in CSBMs (CSBMS/Week) Over 12-week Treatment Period, Mean Replacement Approach
12-Week Treatment Period
Change From Baseline in SBM (SBMs/Week) Over 12-week Treatment Period, Mean Replacement Approach
12-Week Treatment Period
Change From Baseline in Stool Consistency Score Over the 12-week Treatment Period, Mean Replacement Approach
12-Week Treatment Period
Change From Baseline in Straining Score Over 12-Week Treatment Period, Mean Replacement Approach
12-Week Treatment Period
Study Arms (4)
Plecanatide 3.0 mg
ACTIVE COMPARATORPlecanatide tablets 3.0 mg QD for 12 weeks
Plecanatide 6.0 mg
ACTIVE COMPARATORPlecanatide tablets 6.0 mg QD for 12 weeks
Placebo
PLACEBO COMPARATORMatching placebo tablets QD for 12 weeks
Bisacodyl
OTHERRescue medication
Interventions
Plecanatide tablets QD for 12 weeks
Eligibility Criteria
You may qualify if:
- Male or female aged 18-80, inclusive
- Meets modified Rome III criteria for functional chronic idiopathic constipation for at least 3 months with symptom onset for at least 6 months
- Completed a colonoscopy in accordance with AGA colon cancer screening guidelines (5 years), with no clinically significant findings
- Willing to maintain a stable diet during the study
You may not qualify if:
- Loose stool (mushy) or watery (Bristol score 6 or 7) stool in the absence of any laxative or prohibited medicine for \> 25% of BMs during the 3 months prior to screening visit OR during the 14 day pre-treatment assessment
- Active peptic ulcer disease, diabetes or hypertension not adequately treated or not stable
- History of cathartic colon, laxative, enema abuse, or ischemic colitis
- Fecal impaction within 3 months of screening
- Patient has had /has any: diseases or conditions associated with constipation (GI or CNS), structural abnormality of the GI tract or gastric bypass surgery, pelvic floor dysfunction, pseudo-obstruction, active infectious gastritis, diverticulitis, anal fissures or any disease or condition that can affect GI motility or defecation or can be associated with abdominal pain
- Unexplained and clinically significant "alarm symptoms" including lower GI bleeding, iron-deficiency anemia, weight loss or systemic signs of infection or colitis
- Major surgery, stroke or MI within 60 days of screening
- Participated in a previous plecanatide clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (189)
Synergy Research Site
Birmingham, Alabama, 35242, United States
Synergy Research Site
Dothan, Alabama, 36305, United States
Synergy Research Site
Gulf Shores, Alabama, 36542, United States
Synergy Research Site
Huntsville, Alabama, 35801, United States
Synergy Research Site
Mobile, Alabama, 36695, United States
Synergy Research Site
Mesa, Arizona, 85206, United States
Synergy Research Site
Phoenix, Arizona, 85018, United States
Synergy Research Site
Phoenix, Arizona, 85023, United States
Synergy Research Site
Tempe, Arizona, 85283, United States
Synergy Research Site
Tucson, Arizona, 85712, United States
Synergy Research Site
Hot Springs, Arkansas, 71913, United States
Synergy Research Site
Little Rock, Arkansas, 72211, United States
Synergy Research Site
North Little Rock, Arkansas, 72117, United States
Synergy Research Site
Anaheim, California, 92801, United States
Synergy Research Site
Anaheim, California, 92804, United States
Synergy Research Site
Carlsbad, California, 92008, United States
Synergy Research Site
Cerritos, California, 90703, United States
Synergy Research Site
Chula Vista, California, 91910, United States
Synergy Research Site
El Cajon, California, 92020, United States
Synergy Research Site
Encinitas, California, 92024, United States
Synergy Research Site
Encino, California, 91436, United States
Synergy Research Site
Fountain Valley, California, 92708, United States
Synergy Research Site
Fresno, California, 93726, United States
Synergy Research Site
Hawaiian Gardens, California, 90716, United States
Synergy Research Site
Lancaster, California, 93534, United States
Synergy Research Site
Long Beach, California, 90806, United States
Synergy Research Site
Los Angeles, California, 90015, United States
Synergy Research Site
Los Angeles, California, 90045, United States
Synergy Research Site
Los Angeles, California, 90067, United States
Synergy Research Site
Mission Hills, California, 91345, United States
Synergy Research Site
Murrieta, California, 92562, United States
Synergy Research Site
North Hollywood, California, 91606, United States
Synergy Research Site
Oceanside, California, 92054, United States
Synergy Research Site
Oxnard, California, 93030, United States
Synergy Research Site
Pasadena, California, 91105, United States
Synergy Research Site
Poway, California, 92064, United States
Synergy Research Site
Sacramento, California, 95816, United States
Synergy Research Site
San Diego, California, 92101, United States
Synergy Research Site
San Diego, California, 92103, United States
Synergy Research Site
San Diego, California, 92108, United States
Synergy Research Site
San Diego, California, 92114, United States
Synergy Research Site
Thousand Oaks, California, 91360, United States
Synergy Research Site
Colorado Springs, Colorado, 80907, United States
Synergy Research Site
Colorado Springs, Colorado, 80909, United States
Synergy Research Site
Denver, Colorado, 80218, United States
Synergy Research Site
Denver, Colorado, 80220, United States
Synergy Research Site
Denver, Colorado, 80246, United States
Synergy Research Site
Littleton, Colorado, 80120, United States
Synergy Research Site
Bristol, Connecticut, 06010, United States
Synergy Research Site
Danbury, Connecticut, 06810, United States
Synergy Research Site
Waterbury, Connecticut, 06708, United States
Synergy Research Site
Boynton Beach, Florida, 33426, United States
Synergy Research Site
Clearwater, Florida, 33759, United States
Synergy Research Site
DeLand, Florida, 32720, United States
Synergy Research Site
Fort Lauderdale, Florida, 33306, United States
Synergy Research Site
Fort Lauderdale, Florida, 33308, United States
Synergy Research Site
Hialeah, Florida, 33012, United States
Synergy Research Site
Jupiter, Florida, 33458, United States
Synergy Research Site
Lakeland, Florida, 33805, United States
Synergy Research Site
Lynn Haven, Florida, 32444, United States
Synergy Research Site
Miami, Florida, 33130, United States
Synergy Research Site
Miami, Florida, 33165, United States
Synergy Research Site
Miami, Florida, 33173, United States
Synergy Research Site
Miami, Florida, 33174, United States
Synergy Research Site
Miami, Florida, 33185, United States
Synergy Research Site
Miami, Florida, 33186, United States
Synergy Research Site
Orlando, Florida, 32803, United States
Synergy Research Site
Orlando, Florida, 32806, United States
Synergy Research Site
Port Orange, Florida, 32129, United States
Synergy Research Site
Tampa, Florida, 33604, United States
Synergy Research Site
Tampa, Florida, 33606, United States
Synergy Research Site
Tampa, Florida, 33617, United States
Synergy Research Site
Athens, Georgia, 30606, United States
Synergy Research Site
Augusta, Georgia, 30912, United States
Synergy Research Site
Decatur, Georgia, 30032, United States
Synergy Research Site
Decatur, Georgia, 30033, United States
Synergy Research Site
Johns Creek, Georgia, 30097, United States
Synergy Research Site
Oakwood, Georgia, 30566, United States
Synergy Research Site
Savannah, Georgia, 31406, United States
Synergy Research Site
Smyrna, Georgia, 30082, United States
Synergy Research Site
Evanston, Illinois, 60201, United States
Synergy Research Site
Clive, Iowa, 50325, United States
Synergy Research Site
Augusta, Kansas, 67010, United States
Synergy Research Site
Newton, Kansas, 67114, United States
Synergy Research Site
Shawnee Mission, Kansas, 66218, United States
Synergy Research Site
Wichita, Kansas, 67205, United States
Synergy Research Site
Wichita, Kansas, 67207, United States
Synergy Research Site
Lexington, Kentucky, 40503, United States
Synergy Research Site
Lexington, Kentucky, 40504, United States
Synergy Research Site
Bastrop, Louisiana, 71220, United States
Synergy Research Site
Marrero, Louisiana, 70072, United States
Synergy Research Site
Metairie, Louisiana, 70006, United States
Synergy Research Site
New Orleans, Louisiana, 70115, United States
Synergy Research Site
New Orleans, Louisiana, 70119, United States
Synergy Research Site
Shreveport, Louisiana, 71103, United States
Synergy Research Site
Chevy Chase, Maryland, 20815, United States
Synergy Research Site
Boston, Massachusetts, 02131, United States
Synergy Research Site
Brockton, Massachusetts, 02302, United States
Synergy Research Site
New Bedford, Massachusetts, 02740, United States
Synergy Research Site
Chesterfield, Michigan, 48047, United States
Synergy Research Site
Flint, Michigan, 48504, United States
Synergy Research Site
Rochester, Michigan, 48307, United States
Synergy Research Site
Saginaw, Michigan, 48604, United States
Synergy Research Site
Southfield, Michigan, 48034, United States
Synergy Research Site
Biloxi, Mississippi, 39531, United States
Synergy Research Site
Jackson, Mississippi, 39202, United States
Synergy Research Site
St Louis, Missouri, 63128, United States
Synergy Research Site
Omaha, Nebraska, 68114, United States
Synergy Research Site
Henderson, Nevada, 89014, United States
Synergy Research Site
Las Vegas, Nevada, 89119, United States
Synergy Research Site
Las Vegas, Nevada, 89121, United States
Synergy Research Site
Reno, Nevada, 89511, United States
Synergy Research Site
Lebanon, New Hampshire, 03756, United States
Synergy Research Site
Lodi, New Jersey, 07644, United States
Synergy Research Site
Ocean City, New Jersey, 07712, United States
Synergy Research Site
Albuquerque, New Mexico, 87109, United States
Synergy Research Site
Brooklyn, New York, 11206, United States
Synergy Research Site
Great Neck, New York, 11023, United States
Synergy Research Site
North Massapequa, New York, 11758, United States
Synergy Research Site
Cary, North Carolina, 27518, United States
Synergy Research Site
Chapel Hill, North Carolina, 27599, United States
Synergy Research Site
Charlotte, North Carolina, 28210, United States
Synergy Research Site
Charlotte, North Carolina, 28277, United States
Synergy Research Site
Greensboro, North Carolina, 27403, United States
Synergy Research Site
Kinston, North Carolina, 28501, United States
Synergy Research Site
Raleigh, North Carolina, 27612, United States
Synergy Research Site
Wilmington, North Carolina, 28401, United States
Synergy Research Site
Winston-Salem, North Carolina, 27103, United States
Synergy Research Site
Fargo, North Dakota, 58103, United States
Synergy Research Site
Beavercreek, Ohio, 45432, United States
Synergy Research Site
Centerville, Ohio, 45459, United States
Synergy Research Site
Cincinnati, Ohio, 45246, United States
Synergy Research Site
Hilliard, Ohio, 43026, United States
Synergy Research Site
Huber Heights, Ohio, 45424, United States
Synergy Research Site
Maumee, Ohio, 43537, United States
Synergy Research Site
Mentor, Ohio, 44060, United States
Synergy Research Site
Oakwood, Ohio, 45419, United States
Synergy Research Site
Stow, Ohio, 44224, United States
Synergy Research Site
Norman, Oklahoma, 73071, United States
Synergy Research Site
Oklahoma City, Oklahoma, 73102, United States
Synergy Research Site
Limerick, Pennsylvania, 19468, United States
Synergy Research Site
Philadelphia, Pennsylvania, 19152, United States
Synergy Research Site
Smithfield, Pennsylvania, 15478, United States
Synergy Research Site
Yardley, Pennsylvania, 19067, United States
Synergy Research Site
Anderson, South Carolina, 29621, United States
Synergy Research Site
Charleston, South Carolina, 28406, United States
Synergy Research Site
Columbia, South Carolina, 29204, United States
Synergy Research Site
Chattanooga, Tennessee, 37421, United States
Synergy Research Site
Jackson, Tennessee, 38305, United States
Synergy Research Site
Nashville, Tennessee, 37205, United States
Synergy Research Site
New Tazewell, Tennessee, 37825, United States
Synergy Research Site
Austin, Texas, 78745, United States
Synergy Research Site
Dallas, Texas, 75230, United States
Synergy Research Site
Dallas, Texas, 75234, United States
Synergy Research Site
Houston, Texas, 77043, United States
Synergy Research Site
Houston, Texas, 77062, United States
Synergy Research Site
Houston, Texas, 77070, United States
Synergy Research Site
Houston, Texas, 77090, United States
Synergy Research Site
Killeen, Texas, 76543, United States
Synergy Research Site
Plano, Texas, 75093, United States
Synergy Research Site
San Angelo, Texas, 76904, United States
Synergy Research Site
San Antonio, Texas, 78209, United States
Synergy Research Site
San Antonio, Texas, 78258, United States
Synergy Research Site
Sugar Land, Texas, 77479, United States
Synergy Research Site
Logan, Utah, 84341, United States
Synergy Research Site
Salt Lake City, Utah, 84124, United States
Synergy Research Site
St. George, Utah, 84790, United States
Synergy Research Site
Christiansburg, Virginia, 24073, United States
Synergy Research Site
Henrico, Virginia, 23233, United States
Synergy Research Site
Lynchburg, Virginia, 24502, United States
Synergy Research Site
Norfolk, Virginia, 23502, United States
Synergy Research Site
Norfolk, Virginia, 23507, United States
Synergy Research Site
Richmond, Virginia, 23294, United States
Synergy Research Site
Virginia Beach, Virginia, 23455, United States
Synergy Research Site
Seattle, Washington, 98105, United States
Synergy Research Site
Tacoma, Washington, 98405, United States
Synergy Research Site
Wauwatosa, Wisconsin, 53226, United States
Synergy Research Site
Kelowna, British Columbia, V1Y 1Z9, Canada
Synergy Research Site
Bridgewater, Nova Scotia, B4V 3N2, Canada
Synergy Research Site
Brampton, Ontario, L6T 0G1, Canada
Synergy Research Site
Cambridge, Ontario, N1S 2M6, Canada
Synergy Research Site
Greater Sudbury, Ontario, P3E 1H5, Canada
Synergy Research Site
London, Ontario, N5Y 5K7, Canada
Synergy Research Site
Oshawa, Ontario, L1H 1B9, Canada
Synergy Research Site
Toronto, Ontario, M3H 5S4, Canada
Synergy Research Site
Toronto, Ontario, M9W 4L6, Canada
Synergy Research Site
Mirabel, Quebec, J7J 2K8, Canada
Synergy Research Site
Pointe-Claire, Quebec, H9R 4S3, Canada
Synergy Research Site
Saint Romuald, Quebec, G6W 5M6, Canada
Related Publications (5)
Cash BD, Sharma A, Walker A, Laitman AP, Chang L. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation. Neurogastroenterol Motil. 2023 Sep;35(9):e14632. doi: 10.1111/nmo.14632. Epub 2023 Jun 18.
PMID: 37332239DERIVEDRao SSC, Laitman AP, Miner PB Jr. Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide. Clin Transl Gastroenterol. 2023 Jul 1;14(7):e00598. doi: 10.14309/ctg.0000000000000598.
PMID: 37162147DERIVEDMoshiree B, Schoenfeld P, Franklin H, Rezaie A. The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials. Clin Ther. 2022 Jan;44(1):98-110.e1. doi: 10.1016/j.clinthera.2021.11.009. Epub 2022 Jan 25.
PMID: 35086735DERIVEDMenees SB, Franklin H, Chey WD. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older. Clin Ther. 2020 Jul;42(7):1406-1414.e4. doi: 10.1016/j.clinthera.2020.05.012. Epub 2020 Jul 10.
PMID: 32660770DERIVEDMiner PB Jr, Koltun WD, Wiener GJ, De La Portilla M, Prieto B, Shailubhai K, Layton MB, Barrow L, Magnus L, Griffin PH. A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. Am J Gastroenterol. 2017 Apr;112(4):613-621. doi: 10.1038/ajg.2016.611. Epub 2017 Feb 7.
PMID: 28169285DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Patrick H. Griffin
- Organization
- Synergy Pharmaceuticals Inc.
Study Officials
- STUDY DIRECTOR
Mary Beth Layton
Synergy Pharmaceuticals Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2013
First Posted
November 13, 2013
Study Start
November 1, 2013
Primary Completion
April 1, 2015
Study Completion
June 1, 2015
Last Updated
December 26, 2019
Results First Posted
March 21, 2019
Record last verified: 2019-12